Compass’ range

How Compass’ technology generates large multispecific libraries

Compass Therapeutics LLC combines human cell display, high throughput antibody screening and a multispecific engineering platform to develop large libraries of cancer and autoimmune therapies.

Traditional approaches to antibody discovery use hybridoma fusions in animals, phage display or yeast cell surface display, followed by a humanizing step, which co-founder and CEO Thomas Schuetz said generates smaller libraries of antibodies with less epitopic diversity than Compass’ approach.


Read the full 662 word article

How to gain access

Continue reading with a
two-week free trial.